Curavit

Operates as a digital-first CRO running virtual and hybrid studies, with particular focus on digital therapeutics and software-based interventions where the product itself is delivered remotely.

CRO-style scoped budget with unit costs.

Whatever the structure, convert it to cost per randomized patient before you compare proposals. Cost per referral is the number vendors prefer to quote and the number that tells you least.

• Positioned specifically for digital therapeutic and software-as-intervention trials
• Lean operating model aimed at smaller sponsors

• Ask how many studies it has run in your therapeutic area and who would staff yours

Worth it when: Digital health and DTx sponsors running remote studies.

Not worth it when: Large multinational drug programs with complex safety monitoring.

• Science 37Decentralized trial operating system with telemedicine investigators and nurses.
• Lindus HealthAll-in-one CRO bundling recruitment, sites, and eClinical with fixed pricing.
• TrialSparkTechnology-led trial execution; strategy has shifted toward drug development.

• Science 37 vs Curavit — Two decentralized models at different scales.

Ask for the referral-to-randomization ratio on three studies resembling yours, in the same indication and the same countries. If a vendor will not give it, that is the answer. If your enrollment forecast itself is the shaky part, our sister publication Rock Enroll covers forecasting and rescue in depth.